Catalyst
Results from the study involving 60 patients at Vall d'Hebron University Hospital, expected to provide insights into the effectiveness of AI in IBD surveillance.
Humanexa recommends Monitor.
Date
July 10, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.